Laleh Amiri-Kordestani1, Richard Pazdur2,3. 1. Office of Oncologic Diseases, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA. Laleh.AmiriKordestani@fda.hhs.gov. 2. Office of Oncologic Diseases, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA. 3. Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, MD, USA.
Authors: Nina Kim; Kelly J Norsworthy; Sriram Subramaniam; Haiyan Chen; Michael L Manning; Eliford Kitabi; Justin Earp; Lori A Ehrlich; Olanrewaju O Okusanya; Jonathon Vallejo; Brenda J Gehrke; R Angelo de Claro; Richard Pazdur Journal: Clin Cancer Res Date: 2022-08-15 Impact factor: 13.801
Authors: Donna R Rivera; Paul G Kluetz; Kald Abdallah; Sundeep Agrawal; Derek C Angus; Robert M Califf; Elizabeth Garrett-Mayer; Randall Hyer; Douglas R Lowy; Samir N Khleif Journal: Cancer J Date: 2022 Mar-Apr 01 Impact factor: 2.074